{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:09:16Z","timestamp":1762430956461},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11764-015-0429-z","type":"journal-article","created":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T21:14:13Z","timestamp":1422825253000},"page":"523-531","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry"],"prefix":"10.1007","volume":"9","author":[{"given":"Pauline A. J.","family":"Vissers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floortje","family":"Mols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa S. Y.","family":"Thong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans","family":"Pouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Vreugdenhil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lonneke V.","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"issue":"4","key":"429_CR1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/003335491112600403","volume":"126","author":"AK Parekh","year":"2011","unstructured":"Parekh AK, Goodman RA, Gordon C, Koh HK. Managing multiple chronic conditions: a strategic framework for improving health outcomes and quality of life. Public Health Rep. 2011;126(4):460\u201371.","journal-title":"Public Health Rep"},{"issue":"4","key":"429_CR2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengoni","year":"2011","unstructured":"Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430\u20139. doi: 10.1016\/j.arr.2011.03.003 .","journal-title":"Ageing Res Rev."},{"key":"429_CR3","volume-title":"Global status report on noncommunicable diseases","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Global status report on noncommunicable diseases. Geneva: World Health Organization; 2011."},{"issue":"2","key":"429_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005;55(2):74\u2013108. doi: 10.3322\/canjclin.55.2.74 .","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"429_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.24343","volume":"125","author":"RR Huxley","year":"2009","unstructured":"Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125(1):171\u201380. doi: 10.1002\/ijc.24343 .","journal-title":"Int J Cancer"},{"issue":"12","key":"429_CR6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1023\/B:EJEP.0000006612.70245.24","volume":"18","author":"RM Dam van","year":"2003","unstructured":"van Dam RM. Review: The epidemiology of lifestyle and risk for type 2 diabetes. Eur J Epidemiol. 2003;18(12):1115\u201326. doi: 10.1023\/B:EJEP.0000006612.70245.24 .","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"429_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.critrevonc.2005.04.008","volume":"55","author":"MLG Janssen-Heijnen","year":"2005","unstructured":"Janssen-Heijnen MLG, Houterman S, Lemmens VEPP, Louwman MWJ, Maas HAAM, Coebergh JWW. Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach. Crit Rev Oncol Hematol. 2005;55(3):231\u201340. doi: 10.1016\/j.critrevonc.2005.04.008 .","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"429_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137\u201349. doi: 10.1016\/j.diabres.2013.11.002 .","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"429_CR9","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/ijc.22532","volume":"120","author":"LV Poll-Franse van de","year":"2007","unstructured":"van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007;120(9):1986\u201392. doi: 10.1002\/ijc.22532 .","journal-title":"Int J Cancer"},{"issue":"7","key":"429_CR10","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10620-009-0944-8","volume":"55","author":"K Stein","year":"2010","unstructured":"Stein K, Snyder C, Barone B, Yeh H-C, Peairs K, Derr R, et al. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and Meta-Analysis. Dig Dis Sci. 2010;55(7):1839\u201351. doi: 10.1007\/s10620-009-0944-8 .","journal-title":"Dig Dis Sci"},{"issue":"13","key":"429_CR11","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1200\/JCO.2008.17.5935","volume":"27","author":"TP Srokowski","year":"2009","unstructured":"Srokowski TP, Fang S, Hortobagyi GN, Giordano SH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol. 2009;27(13):2170\u20136. doi: 10.1200\/jco.2008.17.5935 .","journal-title":"J Clin Oncol"},{"issue":"2","key":"429_CR12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MJT.0b013e3181a3e50b","volume":"17","author":"Z Nurgalieva","year":"2010","unstructured":"Nurgalieva Z, Xia R, Liu C-C, Burau K, Hardy D, Du XL. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer. Am J Ther. 2010;17(2):148\u201358. doi: 10.1097\/MJT.0b013e3181a3e50b .","journal-title":"Am J Ther"},{"issue":"16","key":"429_CR13","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"A Gramont de","year":"2000","unstructured":"de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18(16):2938\u201347.","journal-title":"J Clin Oncol"},{"issue":"16","key":"429_CR14","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2006.08.6652","volume":"25","author":"SR Land","year":"2007","unstructured":"Land SR, Kopec JA, Cecchini RS, Ganz PA, Wieand HS, Colangelo LH, et al. Neurotoxicity From oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol. 2007;25(16):2205\u201311. doi: 10.1200\/jco.2006.08.6652 .","journal-title":"J Clin Oncol"},{"issue":"5","key":"429_CR15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2010-0248","volume":"16","author":"SB Park","year":"2011","unstructured":"Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC. Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. Oncologist. 2011;16(5):708\u201316. doi: 10.1634\/theoncologist. 2010-0248 .","journal-title":"Oncologist"},{"issue":"21","key":"429_CR16","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","volume":"31","author":"F Mols","year":"2013","unstructured":"Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol. 2013;31(21):2699\u2013707. doi: 10.1200\/JCO.2013.49.1514 .","journal-title":"J Clin Oncol"},{"issue":"10","key":"429_CR17","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","volume":"34","author":"CA Abbott","year":"2011","unstructured":"Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34(10):2220\u20134. doi: 10.2337\/dc11-1108 .","journal-title":"Diabetes Care"},{"issue":"5","key":"429_CR18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jdiacomp.2006.08.002","volume":"21","author":"SD Candrilli","year":"2007","unstructured":"Candrilli SD, Davis KL, Kan HJ, Lucero MA, Rousculp MD. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complicat. 2007;21(5):306\u201314. doi: 10.1016\/j.jdiacomp.2006.08.002 .","journal-title":"J Diabetes Complicat"},{"issue":"7","key":"429_CR19","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/diacare.27.7.1591","volume":"27","author":"EW Gregg","year":"2004","unstructured":"Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the US adult population > =40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004;27(7):1591\u20137.","journal-title":"Diabetes Care"},{"issue":"6","key":"429_CR20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521\u201334. doi: 10.1016\/S1474-4422(12)70065-0 .","journal-title":"Lancet Neurol"},{"issue":"S1","key":"429_CR21","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/dmrr.856","volume":"24","author":"CHM Schie van","year":"2008","unstructured":"van Schie CHM. Neuropathy: mobility and quality of life. Diabetes Metab Res Rev. 2008;24(S1):S45\u201351. doi: 10.1002\/dmrr.856 .","journal-title":"Diabetes Metab Res Rev"},{"key":"429_CR22","doi-asserted-by":"crossref","unstructured":"Bruun C, Siersma V, Guassora AD, Holstein P, de Fine ON. Amputations and foot ulcers in patients newly diagnosed with Type\u00a02 diabetes mellitus and observed for 19\u00a0years. The role of age, gender and co-morbidity. Diabet Med. 2013;30(8):964\u201372. doi: 10.1111\/dme.12196 .","DOI":"10.1111\/dme.12196"},{"key":"429_CR23","doi-asserted-by":"crossref","unstructured":"Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. The Lancet.366(9498):1719-24. doi: 10.1016\/S0140-6736(05)67698-2","DOI":"10.1016\/S0140-6736(05)67698-2"},{"issue":"14","key":"429_CR24","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ejca.2011.04.034","volume":"47","author":"LV Poll-Franse van de","year":"2011","unstructured":"van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14):2188\u201394. doi: 10.1016\/j.ejca.2011.04.034 .","journal-title":"Eur J Cancer"},{"key":"429_CR25","unstructured":"Coebergh JWW, Janssen-Heijnen MLG, Louwman WJ, Voogd AC. Cancer incidence and survival in the south of the Netherlands, 1955-1999 & incidence in the north of Belgium, 1996-1998 [CD-ROM]. Eindhoven: Comprehensive Cancer Centre South (IKZ); 2001."},{"issue":"3","key":"429_CR26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpsychores.2012.07.004","volume":"73","author":"F Mols","year":"2012","unstructured":"Mols F, Denollet J, Kaptein AA, Reemst PH, Thong MS. The association between Type D personality and illness perceptions in colorectal cancer survivors: a study from the population-based PROFILES registry. J Psychosom Res. 2012;73(3):232\u20139. doi: 10.1016\/j.jpsychores.2012.07.004 .","journal-title":"J Psychosom Res"},{"issue":"2","key":"429_CR27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/art.10993","volume":"49","author":"O Sangha","year":"2003","unstructured":"Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156\u201363. doi: 10.1002\/art.10993 .","journal-title":"Arthritis Rheum"},{"issue":"8","key":"429_CR28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer. 2005;41(8):1135\u20139. doi: 10.1016\/j.ejca.2005.02.012 .","journal-title":"Eur J Cancer"},{"issue":"4","key":"429_CR29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/annonc\/mdp509","volume":"21","author":"RK Ramanathan","year":"2010","unstructured":"Ramanathan RK, Rothenberg ML, de Gramont A, Tournigand C, Goldberg RM, Gupta S, et al. Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. Ann Oncol. 2010;21(4):754\u20138. doi: 10.1093\/annonc\/mdp509 .","journal-title":"Ann Oncol"},{"issue":"25","key":"429_CR30","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.2011.39.8446","volume":"30","author":"BP Schneider","year":"2012","unstructured":"Schneider BP, Zhao F, Wang M, Stearns V, Martino S, Jones V, et al. Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer. J Clin Oncol. 2012;30(25):3051\u20137. doi: 10.1200\/JCO.2011.39.8446 .","journal-title":"J Clin Oncol"},{"issue":"6","key":"429_CR31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/02841860902806609","volume":"48","author":"EE Brouwers","year":"2009","unstructured":"Brouwers EE, Huitema AD, Boogerd W, Beijnen JH, Schellens JH. Persistent neuropathy after treatment with cisplatin and oxaliplatin. Acta Oncol. 2009;48(6):832\u201341. doi: 10.1080\/02841860902806609 .","journal-title":"Acta Oncol"},{"issue":"1","key":"429_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0609.2010.01533.x","volume":"86","author":"MA Dimopoulos","year":"2011","unstructured":"Dimopoulos MA, Mateos MV, Richardson PG, Schlag R, Khuageva NK, Shpilberg O, et al. Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study. Eur J Haematol. 2011;86(1):23\u201331. doi: 10.1111\/j.1600-0609.2010.01533.x .","journal-title":"Eur J Haematol"},{"issue":"5","key":"429_CR33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00520-012-1667-5","volume":"21","author":"B Vincenzi","year":"2013","unstructured":"Vincenzi B, Frezza AM, Schiavon G, Spoto C, Silvestris N, Addeo R, et al. Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV. Support Care Cancer. 2013;21(5):1313\u20139. doi: 10.1007\/s00520-012-1667-5 .","journal-title":"Support Care Cancer"},{"issue":"4","key":"429_CR34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clcc.2012.05.002","volume":"11","author":"AN Uwah","year":"2012","unstructured":"Uwah AN, Ackler J, Leighton Jr JC, Pomerantz S, Tester W. The effect of diabetes on oxaliplatin-induced peripheral neuropathy. Clin Colorectal Cancer. 2012;11(4):275\u20139. doi: 10.1016\/j.clcc.2012.05.002 .","journal-title":"Clin Colorectal Cancer"},{"issue":"10","key":"429_CR35","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/dme.12253","volume":"30","author":"MMJ Zanders","year":"2013","unstructured":"Zanders MMJ, van Steenbergen LN, Haak HR, Rutten HJT, Pruijt JFM, Poortmans PMP, et al. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study. Diabet Med. 2013;30(10):1181\u20138. doi: 10.1111\/dme.12253 .","journal-title":"Diabet Med"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-015-0429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-015-0429-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-015-0429-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T07:55:46Z","timestamp":1566287746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-015-0429-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1007\/s11764-015-0429-z","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}